Entheon Biomedical (XCNQ:ENBI) Purchase Of Investment : C$0.00 Mil (TTM As of Feb. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Entheon Biomedical Purchase Of Investment?

Entheon Biomedical's purchase of investment for the three months ended in Feb. 2024 was C$0.00 Mil. It means Entheon Biomedical spent C$0.00 Mil on purchasing investments. Entheon Biomedical's purchase of investment for the trailing twelve months (TTM) ended in Feb. 2024 was C$0.00 Mil.

Compared with last quarter (C$0.00 Mil in Nov. 2023 ), Entheon Biomedical spent the same money on purchasing investments in Feb. 2024 (C$0.00 Mil).

Entheon Biomedical Purchase Of Investment Historical Data

The historical data trend for Entheon Biomedical's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Entheon Biomedical Purchase Of Investment Chart

Entheon Biomedical Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Nov21

Nov22

Nov23

Purchase Of Investment

Get a 7-Day Free Trial

-0.41

Entheon Biomedical Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Purchase Of Investment	Get a 7-Day Free Trial															-	-	-	-	-

Entheon Biomedical Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

Entheon Biomedical Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of Entheon Biomedical's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Entheon Biomedical (XCNQ:ENBI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Entheon Biomedical Corp (XCNQ:ENBI) » Definitions » Purchase Of Investment

Comparable Companies

Traded in Other Exchanges

ENTBF:USA 1XU1:Germany

Address

999 West Broadway Street, Suite 720, Vancouver, BC, CAN, V5Z 1K5

Website

https://www.entheonbiomedical.com

Entheon Biomedical Corp is a biotechnology research and development company committed to developing and commercializing a portfolio of safe and effective Dimethyltryptamine based psychedelic therapeutic products (DMT Products) for the purposes of treating addiction and substance use disorders. Entheon intends to generate revenue through the sale of its DMT Products to physicians, clinics, and licensed psychiatrists in the United States, certain countries in the European Union, and throughout Canada.

Entheon Biomedical (XCNQ:ENBI) Headlines

No Headlines